Blue Trust’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-170
Closed -$1K – 2655
2023
Q1
$1K Sell
170
-23
-12% -$325 ﹤0.01% 2259
2022
Q4
$1K Sell
193
-102
-35% -$720 ﹤0.01% 2184
2022
Q3
$2K Buy
+295
New +$2.2K ﹤0.01% 1862

Blue Trust's AMYT Position: Q2 2023 in Review

Blue Trust sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 170 shares — an estimated $1K sold.

Blue Trust first reported a position in AMYT in Q3 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Blue Trust reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
  • Blue Trust sold 170 Amryt Pharma shares in Q2 2023, an estimated $1K.
  • Blue Trust first reported a position in Amryt Pharma in Q3 2022 and held it in 3 quarters.
  • Blue Trust's Amryt Pharma position peaked at $2K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.

Based on Blue Trust's 13F filing for Q2 2023, filed 14 Jul 2023.